The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Enhanced Transdermal Drug Delivery by Transfersome-Embedded Oligopeptide Hydrogel for Topical Chemotherapy of Melanoma
Abstract
Topical administration of anticancer drugs provides a potential chemotherapeutic modality with high patient compliance for cutaneous melanoma. However, the drug delivery efficiency is highly limited by physiological barriers from the skin to the tumor, which cannot acquire desired therapeutic efficacy. Herein, we propose a paintable oligopeptide hydrogel containing paclitaxel (PTX)-encapsulated cell-penetrating-peptide (CPP)-modified transfersomes (PTX-CTs) to enhance transdermal PTX delivery for topical melanoma treatment. After being plastered on the skin above the melanoma tumor, the PTX-CTs-embedded hydrogel (PTX-CTs/Gel) as a patch provided prolonged retention capacity of the PTX-CTs on the skin. The PTX-CTs with superior deformability could efficiently squeeze through the channels in the stratum coreum, and the surfactant components improved the fluidity of the lipid molecules in the stratum corneum to further enhance the skin permeation. Moreover, the CPP modification rendered the PTX-CT-enhanced penetration in the skin and tumor stroma as well as efficient transportation in the tumor cells. The PTX-CTs were shown to effectively slow the tumor growth in combination with the systemic chemotherapy using Taxol, the commercial PTX formulation on the xenograft B10F16 melanoma mouse model.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002
Prausnitz, M. R., & Langer, R. (2008) · Nature Biotechnology · doi:10.1038/nbt.1504 · Cited by 3,517
Delivering nanomedicine to solid tumors
Jain, R. K., & Stylianopoulos, T. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.139 · Cited by 3,180
Lee, H., Choi, T. K., Lee, Y. B., Cho, H. R., Ghaffari, R., Wang, L., Choi, H. J., Chung, T. D., Lu, N., Hyeon, T., et al. (2016) · Nature Nanotechnology · doi:10.1038/nnano.2016.38 · Cited by 1,802
How Taxol/paclitaxel kills cancer cells
Weaver, B. A. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-04-0916 · Cited by 1,547
Microneedles for transdermal drug delivery
Prausnitz, M. R. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.023 · Cited by 1,521
Miller, A. J., & Mihm, M. C. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052166 · Cited by 1,339
Enhanced Cancer Immunotherapy by Microneedle Patch-Assisted Delivery of Anti-PD1 Antibody
Wang, C., Ye, Y., Hochu, G. M., Sadeghifar, H., & Gu, Z. (2016) · Nano Letters · doi:10.1021/acs.nanolett.5b05030 · Cited by 784
Particle size of liposomes influences dermal delivery of substances into skin
Verma, D. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00183-2 · Cited by 702
Rai, V. K., Mishra, N., Yadav, K. S., & Yadav, N. P. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.11.049 · Cited by 619
Nanoparticles and nanofibers for topical drug delivery
Goyal, R., Macri, L. K., Kaplan, H. M., & Kohn, J. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.10.049 · Cited by 590
Approaches for breaking the barriers of drug permeation through transdermal drug delivery
Alexander, A., Dwivedi, S., Ajazuddin, Giri, T. K., Saraf, S., Saraf, S., & Tripathi, D. K. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.09.017 · Cited by 563
Permeation enhancer strategies in transdermal drug delivery
Marwah, H., Garg, T., Goyal, A. K., & Rath, G. (2016) · Drug Delivery · doi:10.3109/10717544.2014.935532 · Cited by 529
The structure and function of the stratum corneum
Menon, G. K., Cleary, G. W., & Lane, M. E. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.06.005 · Cited by 467
Malignant melanoma: prevention, early detection, and treatment in the 21st century
Rigel, D. S., & Carucci, J. A. (2000) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.50.4.215 · Cited by 461
Deformable liposomes and ethosomes: Mechanism of enhanced skin delivery
Elsayed, M. M. A., Abdallah, O. Y., Naggar, V. F., & Khalafallah, N. M. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.05.027 · Cited by 383
A melanin-mediated cancer immunotherapy patch
Ye, Y., Wang, C., Zhang, X., Hu, Q., Zhang, Y., Liu, Q., Wen, D., Milligan, J., Bellotti, A., Huang, L., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aan5692 · Cited by 381
Skin permeabilization for transdermal drug delivery: recent advances and future prospects
Schoellhammer, C. M., Blankschtein, D., & Langer, R. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.875528 · Cited by 376
Jiang, T., Zhang, Z., Zhang, Y., Lv, H., Zhou, J., Li, C., Hou, L., & Zhang, Q. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.09.027 · Cited by 359
Self-citationYang, G., Li, X., He, Y., Ma, J., Ni, G., & Zhou, S. (2018) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2017.12.003 · Cited by 336
Polymeric microneedles for transdermal protein delivery
Ye, Y., Yu, J., Wen, D., Kahkoska, A. R., & Gu, Z. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.01.015 · Cited by 324
Jiang, T., Mo, R., Bellotti, A., Zhou, J., & Gu, Z. (2014) · Advanced Functional Materials · doi:10.1002/adfm.201303222 · Cited by 298
Self-citationTransfersomes for transdermal drug delivery
Benson, H. A. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.6.727 · Cited by 296
Ultrasound mediated transdermal drug delivery
Azagury, A., Khoury, L., Enden, G., & Kost, J. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.01.007 · Cited by 294
Rancan, F., Gao, Q., Graf, C., Troppens, S., Hadam, S., Hackbarth, S., Kembuan, C., Blume-Peytavi, U., Rühl, E., Lademann, J., et al. (2012) · ACS Nano · doi:10.1021/nn301622h · Cited by 288
Topical and cutaneous delivery using nanosystems
Roberts, M., Mohammed, Y., Pastore, M., Namjoshi, S., Yousef, S., Alinaghi, A., Haridass, I., Abd, E., Leite-Silva, V., Benson, H., et al. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.12.022 · Cited by 282
Potentials of new nanocarriers for dermal and transdermal drug delivery
Neubert, R. H. H. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.11.003 · Cited by 250
Transdermal iontophoresis: combination strategies to improve transdermal iontophoretic drug delivery
Wang, Y., Thakur, R., Fan, Q., & Michniak, B. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.12.008 · Cited by 236
Jiang, T., Sun, W., Zhu, Q., Burns, N. A., Khan, S. A., Mo, R., & Gu, Z. (2015) · Advanced Materials · doi:10.1002/adma.201404498 · Cited by 227
Self-citationA practical assessment of transdermal drug delivery by skin electroporation
Prausnitz, M. R. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00063-5 · Cited by 207
An Implantable Active-Targeting Micelle-in-Nanofiber Device for Efficient and Safe Cancer Therapy
Yang, G., Wang, J., Wang, Y., Li, L., Guo, X., & Zhou, S. (2015) · ACS Nano · doi:10.1021/nn504573u · Cited by 201
Non-covalently functionalized single-walled carbon nanotube for topical siRNA delivery into melanoma
Siu, K. S., Chen, D., Zheng, X., Zhang, X., Johnston, N., Liu, Y., Yuan, K., Koropatnick, J., Gillies, E. R., & Min, W.-P. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.12.079 · Cited by 175
Ashtikar, M., Nagarsekar, K., & Fahr, A. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.09.008 · Cited by 161
Photodynamic therapy of melanoma skin cancer using carbon dot – chlorin e6 – hyaluronate conjugate
Beack, S., Kong, W. H., Jung, H. S., Do, I. H., Han, S., Kim, H., Kim, K. S., Yun, S. H., & Hahn, S. K. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.08.027 · Cited by 146
Magnetophoresis for enhancing transdermal drug delivery: Mechanistic studies and patch design
Murthy, S. N., Sammeta, S. M., & Bowers, C. P. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.015 · Cited by 129
Pérez, D. G., Suman, V. J., Fitch, T. R., AMATRUDA, T. T., Morton, R. F., Jilani, S. Z., Constantinou, C. L., Egner, J. R., Kottschade, L. A., & Markovic, S. N. (2008) · Cancer · doi:10.1002/cncr.23987 · Cited by 125
Seong, J. S., Yun, M. E., & Park, S. N. (2017) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2017.11.098 · Cited by 114
Zhu, Q., Chen, X., Xu, X., Zhang, Y., Zhang, C., & Mo, R. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201707371 · Cited by 105
Self-citationJiang, T., Shen, S., Wang, T., Li, M., He, B., & Mo, R. (2017) · Nano Letters · doi:10.1021/acs.nanolett.7b03371 · Cited by 56
Self-citationHyaluronate–Gold Nanorod/DR5 Antibody Complex for Noninvasive Theranosis of Skin Cancer
Lee, H., Lee, J. H., Kim, J., Mun, J., Chung, J., Koo, H., Kim, C., Yun, S. H., & Hahn, S. K. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b11319 · Cited by 41
Cited by
Transfersomes: A Promising Nanoencapsulation Technique for Transdermal Drug Delivery
Opatha, S. A. T., Titapiwatanakun, V., & Chutoprapat, R. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12090855 · Cited by 537
Emerging Role of Hydrogels in Drug Delivery Systems, Tissue Engineering and Wound Management
Jacob, S., Nair, A. B., Shah, J., Sreeharsha, N., Gupta, S., & Shinu, P. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13030357 · Cited by 485
A review on recent advances in polymer and peptide hydrogels
Mondal, S., Das, S., & Nandi, A. K. (2020) · Soft Matter · doi:10.1039/c9sm02127b · Cited by 416
Advancements in nanoparticle-based treatment approaches for skin cancer therapy
Zeng, L., Gowda, B. H. J., Ahmed, M. G., Abourehab, M. A. S., Chen, Z.-S., Zhang, C., Li, J., & Kesharwani, P. (2023) · Molecular Cancer · doi:10.1186/s12943-022-01708-4 · Cited by 365
Shi, Q., Shen, Q., Liu, Y., Shi, Y., Huang, W., Wang, X., Li, Z., Chai, Y., Wang, H., Hu, X., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.08.012 · Cited by 334
Metadata
- Authors
- Jiang, T., Wang, T., Li, T., Ma, Y., Shen, S., He, B., & Mo, R.
- Venue
- ACS Nano
- Publisher
- American Chemical Society (ACS)
- Published
- 2018-09-05
- Volume
- 12
- Issue
- 10
- Pages
- 9693-9701
- ISSN
- 1936-0851 (ISSN-L)
- 1936-086X
- OpenAlex
- W2891987281
- Cited by
- 278
- References
- 40
- FWCI
- 9.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.